Juri Rappsilber, James Bruce, Colin Combe, Stephen Fried, Andrea Graziadei, Albert J R Heck, Claudio Iacobucci, Alexander Leitner, Karl Mechtler, Petr Novak, Francis O'Reilly, David C Schriemer, Andrea Sinz, Florian Stengel, Konstantinos Thalassinos
{"title":"提高交联质谱可靠性和数据共享的路线图。","authors":"Juri Rappsilber, James Bruce, Colin Combe, Stephen Fried, Andrea Graziadei, Albert J R Heck, Claudio Iacobucci, Alexander Leitner, Karl Mechtler, Petr Novak, Francis O'Reilly, David C Schriemer, Andrea Sinz, Florian Stengel, Konstantinos Thalassinos","doi":"10.1016/j.mcpro.2025.101024","DOIUrl":null,"url":null,"abstract":"<p><p>Crosslinking Mass Spectrometry (MS) can uncover protein-protein interactions and provide structural information on proteins in their native cellular environments. Despite its promise, the field remains hampered by inconsistent data formats, variable approaches to error control, and insufficient interoperability with global data repositories. Recent advances, especially in false discovery rate (FDR) models and pipeline benchmarking, show that Crosslinking MS data can reach a reliability that matches the demand of integrative structural biology. To drive meaningful progress, however, the community must agree on error estimation, open data formats, and streamlined repository submissions. This perspective highlights these challenges, clarifies remaining barriers, and frames practical next steps. Successful field harmonisation will enhance the acceptance of Crosslinking MS in the broader biological community and is critical for the dependability of the data, no matter where it is produced.</p>","PeriodicalId":18712,"journal":{"name":"Molecular & Cellular Proteomics","volume":" ","pages":"101024"},"PeriodicalIF":5.5000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Roadmap for Improving Reliability and Data Sharing in Crosslinking Mass Spectrometry.\",\"authors\":\"Juri Rappsilber, James Bruce, Colin Combe, Stephen Fried, Andrea Graziadei, Albert J R Heck, Claudio Iacobucci, Alexander Leitner, Karl Mechtler, Petr Novak, Francis O'Reilly, David C Schriemer, Andrea Sinz, Florian Stengel, Konstantinos Thalassinos\",\"doi\":\"10.1016/j.mcpro.2025.101024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Crosslinking Mass Spectrometry (MS) can uncover protein-protein interactions and provide structural information on proteins in their native cellular environments. Despite its promise, the field remains hampered by inconsistent data formats, variable approaches to error control, and insufficient interoperability with global data repositories. Recent advances, especially in false discovery rate (FDR) models and pipeline benchmarking, show that Crosslinking MS data can reach a reliability that matches the demand of integrative structural biology. To drive meaningful progress, however, the community must agree on error estimation, open data formats, and streamlined repository submissions. This perspective highlights these challenges, clarifies remaining barriers, and frames practical next steps. Successful field harmonisation will enhance the acceptance of Crosslinking MS in the broader biological community and is critical for the dependability of the data, no matter where it is produced.</p>\",\"PeriodicalId\":18712,\"journal\":{\"name\":\"Molecular & Cellular Proteomics\",\"volume\":\" \",\"pages\":\"101024\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2025-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular & Cellular Proteomics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.mcpro.2025.101024\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular & Cellular Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.mcpro.2025.101024","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
A Roadmap for Improving Reliability and Data Sharing in Crosslinking Mass Spectrometry.
Crosslinking Mass Spectrometry (MS) can uncover protein-protein interactions and provide structural information on proteins in their native cellular environments. Despite its promise, the field remains hampered by inconsistent data formats, variable approaches to error control, and insufficient interoperability with global data repositories. Recent advances, especially in false discovery rate (FDR) models and pipeline benchmarking, show that Crosslinking MS data can reach a reliability that matches the demand of integrative structural biology. To drive meaningful progress, however, the community must agree on error estimation, open data formats, and streamlined repository submissions. This perspective highlights these challenges, clarifies remaining barriers, and frames practical next steps. Successful field harmonisation will enhance the acceptance of Crosslinking MS in the broader biological community and is critical for the dependability of the data, no matter where it is produced.
期刊介绍:
The mission of MCP is to foster the development and applications of proteomics in both basic and translational research. MCP will publish manuscripts that report significant new biological or clinical discoveries underpinned by proteomic observations across all kingdoms of life. Manuscripts must define the biological roles played by the proteins investigated or their mechanisms of action.
The journal also emphasizes articles that describe innovative new computational methods and technological advancements that will enable future discoveries. Manuscripts describing such approaches do not have to include a solution to a biological problem, but must demonstrate that the technology works as described, is reproducible and is appropriate to uncover yet unknown protein/proteome function or properties using relevant model systems or publicly available data.
Scope:
-Fundamental studies in biology, including integrative "omics" studies, that provide mechanistic insights
-Novel experimental and computational technologies
-Proteogenomic data integration and analysis that enable greater understanding of physiology and disease processes
-Pathway and network analyses of signaling that focus on the roles of post-translational modifications
-Studies of proteome dynamics and quality controls, and their roles in disease
-Studies of evolutionary processes effecting proteome dynamics, quality and regulation
-Chemical proteomics, including mechanisms of drug action
-Proteomics of the immune system and antigen presentation/recognition
-Microbiome proteomics, host-microbe and host-pathogen interactions, and their roles in health and disease
-Clinical and translational studies of human diseases
-Metabolomics to understand functional connections between genes, proteins and phenotypes